Zomepirac sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H13ClNO3.Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0185WZ209, chemically known as 5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetic acid but more generally known as zomepirac sodium, which bears US NIH Compound Identifier 5733. European Medicines Agency schedules Zomepirac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05193MIG. Most nations, for tariff and trade purposes, schedule zomepirac sodium under HS 29339990 and SITC 51577. As of Q4 2014, ZOMEPIRAC SODIUM remains US FDA's Preferred Term for this commodity. Zomepirac sodium bears US NLM identifiers UMLS ID C0149477 and NCI Concept Code C62001. SMILES: CC1CC(N(C1C(=O)C2CCC(CC2)CL)C)CC(=O)[O-].O.O.[NA+].